STANDARD EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMSEquity Agreement • February 21st, 2019 • Alzamend Neuro, Inc. • Pharmaceutical preparations
This Agreement is made effective July 02, 2018, (the “Effective Date”) by and between the University of South Florida Research Foundation, Inc. (hereinafter called “ Licensor”), a nonstock, nonprofit Florida corporation, under Chapter 617 Florida Statutes, and a direct support organization of the University of South Florida (“University”) pursuant to section 1004.28 Florida Statutes and Alzamend Neuro Inc. (hereinafter called “Licensee”), a small corporation organized and existing under the laws of Delaware;
